We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Innovative PTCA Catheters Track Tortuous Anatomy

By HospiMedica International staff writers
Posted on 20 Jun 2017
Print article
Image: The Sapphire NC Plus PTCA dilation catheter (Photo courtesy of OrbusNeich).
Image: The Sapphire NC Plus PTCA dilation catheter (Photo courtesy of OrbusNeich).
Two new percutaneous transluminal coronary angioplasty (PTCA) balloon catheters improve myocardial infusion by dilation of coronary artery inclusions.

The OrbusNeich (Hong Kong) Sapphire II PRO and the Sapphire NC Plus PTCA catheters are intended for balloon dilation of the stenotic portion of the coronary artery or bypass graft stenosis in patients with coronary ischemia in order to improve myocardial infusion, and for dilation of the coronary artery following acute myocardial infarction (MI). The Sapphire II Pro has a well-balanced subzero tapered tip with ultra-low profile for effortless entry through tight lesions. Other features include a proprietary XR balloon for high crossability and recrossability, without compromising durability and robustness.

The Sapphire NC Plus is a true non-compliant dilatation balloon featuring TiFo (tight fold) folding of the balloon material for enhanced crossability in the tightest lesions, Hydro-X coating for improved lubricity and passability, and an enhanced distal tip which allows for smooth lesion entry. Besides myocardial infusion, the Sapphire NC Plus is further indicated for dilatation of in-stent restenosis and post-delivery expansion of balloon expandable coronary stents.

“The Sapphire II Pro and Sapphire NC Plus are tried and proven technology in both the interventional coronary and interventional radiology markets outside the US. Entering the US market with our proven coronary dilatation catheters is a long overdue and logical step for our company,” said Scott Addonizio, Chief Operating Officer of OrbusNeich. “Since our establishment in 2005, we have delivered an extensive portfolio of unique products that have changed the lives of patients and their families around the world. Our focus will now include the US market and we are confident our product will be well received.”

PTCA is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle. The percutaneous procedure first places a guide wire and introducer. A diagnostic catheter is advanced through the introducer over the guide wire to reach the aorta, and the guide wire is removed. Fluoroscopy is then used to identify blockages in coronary arteries, and a balloon catheter is advanced to the blockage site to dilate the artery. A stent may be placed to keep the vessel open.

Related Links:
OrbusNeich

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Infant Blood Draw Station
Infant Blood Draw Station

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.